本页面由Tiger Trade Technology Pte. Ltd.提供服务

Atrium Therapeutics

8.25
-0.1400-1.67%
成交量:3.72万
成交额:30.87万
市值:1.41亿
市盈率:-2.14
高:8.48
开:8.40
低:8.23
收:8.40
52周最高:16.77
52周最低:7.63
股本:1,710.56万
流通股本:1,572.10万
量比:0.16
换手率:0.24%
股息:- -
股息率:- -
每股收益(TTM):-3.8578
每股收益(LYR):-3.1905
净资产收益率:-43.98%
总资产收益率:-399.25%
市净率:0.66
市盈率(LYR):-2.59

数据加载中...

2026/10/09

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/10/08

重要事件披露

Form 8-K - Current report
2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/07/28

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/14

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/14

重要事件披露

Form 8-K - Current report
2026/04/27

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/17

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/04/08

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/02/27

重要事件披露

Form 8-K - Current report
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/23

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]